info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Fingolimod (Fingolimod)
505
Article source: Seagull Pharmacy
Nov 05, 2025

Fingolimod is a sphingosine-1-phosphate receptor modulator, mainly used for the treatment of relapsing multiple sclerosis. Since it was first approved in the United States in 2010, it has become one of the important treatment options for multiple sclerosis.

Indications for Fingolimod (Fingolimod)

Primary Indications

Fingolimod is indicated for relapsing multiple sclerosis in patients aged 10 years and older.

Specific conditions include:

Clinically Isolated Syndrome (CIS): Refers to the first episode of neurological symptom events.

Relapsing-Remitting Disease: Characterized by distinct cycles of relapse and remission.

Active Secondary Progressive Disease: Patients who still experience disease activity during the progressive phase of the disease.

Specifications and Characteristic Features of Fingolimod (Fingolimod)

0.25 mg Hard Capsules

Capsule Body Feature: Ivory-colored and opaque.

Capsule Cap Feature: Ivory-colored and opaque.

Marking System: The capsule cap is printed with "FTY 0.25mg" in black radial printing, and the capsule body has a single black radial band.

0.5 mg Hard Capsules

Capsule Body Feature: White and opaque.

Capsule Cap Feature: Bright yellow and opaque.

Anti-Counterfeiting Mark: The capsule cap is printed with the marking "FTY 0.5mg", and the capsule body has two radial bands printed with yellow ink.

Both specifications of capsules can be taken orally once daily, either on an empty stomach or with food.

Storage Methods for Fingolimod (Fingolimod)

Storage Conditions

Fingolimod capsules should be stored in an environment at 20°C to 25°C. Short-term storage within the range of 15°C to 30°C is allowed, but exposure to humid environments must be avoided.

Capsules should be kept in their original bottles or blister packs to prevent moisture from affecting the drug efficacy.

Patients and medical staff should take care to store the drug in a place out of the reach of children and seal it properly after each use.

The storage stability of the drug directly affects its efficacy and safety, so it must be stored and handled in strict accordance with the requirements.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase 想Tablets (Azithromycin)
Azithromycin Tablets (Azithromycin) are a commonly used macrolide antib iotic that plays an important role in the treatment of various bacterial infections.How to Purchase Azithromycin Tablets (Azithr...
Administration of Triumeq
Triumeq is a fixed-dose combination preparation used for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection.Administration of TriumeqAdult DosageThe recommended dose is one tablet ...
Indications for Triumeq
Triumeq is a fixed-dose combination preparation used for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection. It consists of three active ingredients: abacavir, dolutegravir, and la...
How to Purchase Triumeq
Triumeq (Abacavir, Dolutegravir and Lamivudine Tablets) is a fixed-dose combination preparation used for the treatment of HIV-1 infection, containing three active ingredients: abacavir, dolutegravir, ...
How to Use Fingolimod (Fingolimod)
Fingolimod is a sphingosine-1-phosphate receptor modulator, primarily indicated for the treatment of relapsing multiple sclerosis in patients aged 10 years and older, including clinically isolated syn...
Precautions for Administration of Fingolimod (Fingolimod)
Fingolimod is a sphingosine-1-phosphate receptor modulator. It achieves immunomodulatory treatment for multiple sclerosis by blocking the migration of lymphocytes from lymph nodes to the periphery.Pre...
What Are the Side Effects of Fingolimod (Fingolimod)?
As the first oral sphingosine-1-phosphate receptor modulator for the treatment of multiple sclerosis, fingolimod provides patients with a convenient treatment option. However, both doctors and patient...
Indications for Tivozanib Capsules (Fotivda)
Tivozanib Capsules (Fotivda) is a kinase inhibitor that was first approved in the United States in 2021. As an important drug for the treatment of advanced renal cell carcinoma, it blocks tumor angiog...
Related Articles
Mercaptopurine Tablets: Side Effect Management and Storage Guidelines
Mercaptopurine is a chemotherapy drug used to treat acute lymphoblastic leukemia. Understanding its side effects, mastering relief methods, and proper storage are crucial for treatment safety.1. Commo...
Indications, contraindications, and use in special populations for Mercaptopurine Tablets
Mercaptopurine is a chemotherapy drug used to treat acute lymphoblastic leukemia. Clarifying its indications, contraindications, and key points for use in special populations is crucial for treatment ...
Major Side Effects of Cevimeline
Cevimeline is used to improve dry mouth caused by Sjögren's syndrome, but it may cause various side effects when used.I. Major Side Effects of Cevimeline1. Digestive System Side Effects(1) The mos...
Cevimeline: Indications, Contraindications, and Use in Special Populations
Cevimeline is a cholinergic agonist that primarily promotes salivation by stimulating M receptors in the salivary glands.I. Indications1. Core IndicationCevimeline is indicated only for the improvemen...
Indications of Infigratinib
Infigratinib is an oral kinase inhibitor targeting FGFR2, indicated for patients with specific gene mutations in cholangiocarcinoma.I. Indications1. Infigratinib is indicated for adult patients with p...
Common Side Effects of Infigratinib
Infigratinib has shown clear efficacy in the treatment of FGFR2-mutant cholangiocarcinoma, but may also cause various side effects.I. Common Side Effects1. Ocular Side Effects:(1) The most common ocul...
What is Momelotinib?
Momelotinib is an oral kinase inhibitor indicated for the treatment of adults with intermediate or high-risk myelofibrosis with anemia, including primary and secondary myelofibrosis.I. What is Momelot...
What are the common side effects of Momelotinib
Momelotinib is a targeted therapy used for the treatment of intermediate/high-risk myelofibrosis with anemia. Understanding its common side effects, mastering management strategies, and proper storage...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved